| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8278(05)80401-5 |
| P698 | PubMed publication ID | 7989715 |
| P2093 | author name string | B Balkau | |
| J C Trinchet | |||
| M F Gerhardt | |||
| R E Poupon | |||
| C Munz | |||
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| Alcoholic hepatitis: pathogenesis and approaches to treatment. | Q37988931 | ||
| Cholestasis in acute alcoholic liver disease | Q39472622 | ||
| Biochemical and molecular basis of alcohol-induced injury to liver and other tissues | Q39546411 | ||
| Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: A multicenter sequential trial | Q41128243 | ||
| A randomized trial of prednisolone in patients with severe alcoholic hepatitis | Q42125603 | ||
| Relative concentrations of individual nonsulfated bile acids in the serum and bile of patients with cirrhosis | Q43518750 | ||
| Steatosis, cholestasis, and alkaline phosphatase in alcoholic liver disease | Q44840387 | ||
| Fasting serum bile acid level in cirrhosis. A semi-quantitative index of hepatic function. | Q51639492 | ||
| The diagnostic value of fasting individual serum bile acids in anicteric alcoholic liver disease: relation to liver morphology. | Q51639755 | ||
| Fasting serum bile acids in liver disease. A comparison with histological features. | Q51651640 | ||
| Increased serum bile acids in cirrhosis with normal transaminases. | Q51652299 | ||
| Serum cholic and chenodeoxycholic acid conjugates and standard liver function tests in various morphological stages of alcoholic liver disease. | Q51660514 | ||
| Serum bile acids in alcoholic liver disease. Comparison with histological features of the disease | Q51671161 | ||
| Alcoholic liver disease presenting with marked elevation of serum alkaline phosphatase. A combined clinical and pathological study | Q67434319 | ||
| Acute cholestasis, hepatic failure, and fatty liver in the alcoholic | Q67458365 | ||
| Prognostic significance of cholestatic alcoholic hepatitis. VA Cooperative Study Group #119 | Q68841501 | ||
| Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid | Q68925952 | ||
| High-performance liquid chromatographic determination of tauro- and glyco-conjugated bile acids in human serum | Q69700424 | ||
| Serum bile acids. Physiological determinants and results in liver disease | Q70032268 | ||
| Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy | Q70670255 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 235-240 | |
| P577 | publication date | 1994-08-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Serum bile acids and cholestasis in alcoholic hepatitis. Relationship with usual liver tests and histological features | |
| P478 | volume | 21 |
| Q37710980 | A histologic scoring system for prognosis of patients with alcoholic hepatitis |
| Q37023678 | A synthetic biology-based device prevents liver injury in mice |
| Q55396741 | Alcoholic Hepatitis: Lost in Translation. |
| Q35939088 | Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology |
| Q34257042 | Bile acids specifically increase hepatitis C virus RNA-replication |
| Q34210622 | Cholestasis and alcoholic liver disease |
| Q38912884 | Circadian clock control of hepatic lipid metabolism: role of small heterodimer partner (Shp). |
| Q37227362 | Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice. |
| Q41875093 | Disturbances in the murine hepatic circadian clock in alcohol-induced hepatic steatosis |
| Q52588722 | Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis. |
| Q34060924 | Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis |
| Q37722381 | SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling. |
Search more.